How Can We Assess Recent Changes to Vaccine Policy?

Recent shifts in federal vaccine policy are reshaping the core assumptions that have guided public health, the pharmaceutical industry, and clinical practice. What is changing in how vaccines are recommended, administered, and monitored? Where are providers and pediatricians continuing to follow established guidelines? What are the likely consequences for the broader vaccine enterprise, from the incentives that drive development to the infrastructure that supports clinical trials and the systems that track safety and effectiveness at scale? This conversation will bring together leading voices in vaccinology and regulatory science to assess what is at stake and what can be done to protect the nation’s long-term capacity to develop, test, and deliver vaccines.